Treatment of Central Hypocortisolism
The standard treatment for central hypocortisolism is hydrocortisone replacement therapy at a total daily dose of 15-20 mg, typically divided with 2/3 in the morning and 1/3 in early afternoon to mimic physiological cortisol rhythm. 1
Diagnosis and Etiology
Central hypocortisolism (secondary adrenal insufficiency) is characterized by:
- Low morning cortisol with inappropriately low ACTH levels
- Caused by pituitary or hypothalamic disorders affecting ACTH production
- Unlike primary adrenal insufficiency, mineralocorticoid replacement is typically not needed
Treatment Approach
First-Line Treatment: Glucocorticoid Replacement
Hydrocortisone (HC) is the preferred glucocorticoid replacement:
Cortisone acetate (CA) is an alternative:
- Requires activation to hydrocortisone by hepatic 11β-hydroxysteroid dehydrogenase type 1
- Available in 25 mg and 5 mg tablets 2
- Slightly delayed onset of action compared to hydrocortisone
Dosing Considerations
- Weight-based dosing of 8.1 mg/m²/day may be used in some cases 3
- Three-times-daily regimens may provide more physiological cortisol levels 4
- Lower doses (15 mg/day) may be sufficient and reduce risk of bone loss while maintaining quality of life 5
- Avoid evening doses (after 6 PM) to prevent insomnia
Monitoring and Dose Adjustment
- Clinical assessment is the primary method for monitoring adequacy of replacement 2
- Signs of over-replacement: weight gain, insomnia, peripheral edema
- Signs of under-replacement: fatigue, nausea, hypotension, hyponatremia
- Plasma ACTH and serum cortisol are not useful parameters for dose adjustment 2
Patient Education and Emergency Management
Stress dosing education:
- Increase dose 2-3 times during minor illness or stress
- For severe illness or surgery, parenteral hydrocortisone is required
Emergency preparedness:
Adrenal crisis prevention:
- Delays in hydrocortisone administration during emergencies can be fatal 2
- Patients should be educated to increase doses during concurrent illnesses or injury
Special Considerations
- Drug interactions: CYP3A4 inducers/inhibitors can affect hydrocortisone clearance 2
- Surgical management: Patients require stress-dose steroids for procedures
- Central hypothyroidism: When both cortisol and thyroid hormones are deficient, always replace cortisol first to prevent precipitating an adrenal crisis 2
Long-term Follow-up
- Annual clinical assessment for adequacy of replacement
- Monitor for symptoms of under- or over-replacement
- Assess for development of other pituitary hormone deficiencies
- Bone health monitoring may be warranted with long-term therapy
Common Pitfalls to Avoid
- Replacing thyroid hormone before cortisol in patients with multiple pituitary deficiencies (can precipitate adrenal crisis) 2
- Failing to provide adequate stress-dose instructions
- Administering evening doses too late (can cause insomnia)
- Using plasma cortisol levels to adjust maintenance doses
- Inadequate patient education about emergency management
Central hypocortisolism requires lifelong replacement therapy with careful attention to dose adjustments during times of stress or illness to prevent potentially life-threatening adrenal crisis.